B+
Bull case
20%
Probability
Target price
$1.65
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
SNDL
SNDLBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
SNDL combines no debt, substantial liquidity, active buybacks, and a potentially meaningful Parallel transition into U.S. medical cannabis operations.
Posture
Constructive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-10-27 · BMO.
What can break
Continued liquor demand weakness and declining same-store sales.
Momentum
99
Value
64
Sentiment
40
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.15 · Bull $1.65 · Bear $0.75Analysis 2026-08-07; returns require an exact persisted reference.
Earnings
2026-10-27 · BMO
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-07 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $3.53
Why
Momentum99 · Δ7d -
Value64 · Δ7d -0.4
Sentiment40 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-10-27 · BMO.
- • Value remains the lead driver in the composite, 7D delta -0.4.
Contradictions & invalidation
- • Continued liquor demand weakness and declining same-store sales.
- • Coverage is thin, direct peer evidence is limited, and analyst-count, revision, options, social, and insider-activity evidence is unavailable in the packet.
- • The Q2 print showed worsening profitability: revenue declined, gross margin compressed, operating losses returned, and Cannabis Operations was impaired by Jeeter ramp-up inefficiencies.
Catalyst clock
2026-10-27 · BMO
Q2 2026 earnings reset the near-term thesis
Lead driver: Value · See fundamentals
Momentum
99
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
64
47% active weight
Current posture
7d trendFlat
Δ7d
-0.4
Δ21d
-0.9
Sentiment
40
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 99.0 / Value 64.2 / Sentiment 40.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-07. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$1.15
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$0.75
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$317.5M
Beta
0.82
Shares Out
246.12M
P/E (TTM) · Derived
-29.5
P/S (TTM)
0.64
P/FCF (TTM)
10.53
Rev YoY
-3.7%
EPS YoY
-371.6%
Gross Margin
+20.7%
Op Margin
-1.7%
Net Debt
-$75.11M
Current Ratio
4.76
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data